iRhythm Technologies Inc

IRTC

146.470USD

-0.280-0.19%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

iRhythm Technologies Inc's Score

Industry at a Glance

Industry Ranking

40 / 205

Overall Ranking

128 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

iRhythm Technologies Inc Highlights

StrengthsRisks

iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry (MCT) monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 44.03% year-on-year.

Undervalued

The company’s latest PE is -91.11, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 34.59M shares, decreasing 11.79% quarter-over-quarter.

Held by Invesco

Star Investor Invesco holds 33.20K shares of this stock.

Analyst Rating

Based on 16 analysts

Buy

Current Rating

220.200

Target Price

+44.43%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of iRhythm Technologies Inc is 7.11, ranking 103 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 192.88M, representing a year-over-year increase of 30.74%, while its net profit experienced a year-over-year increase of 88.71%.

Score

Industry at a Glance

Previous score

7.11

Change

0



Financials

7.16

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

2.62

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

9.26

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

9.08

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.42

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of iRhythm Technologies Inc is 7.25, ranking 105 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -91.11, which is -87.10% below the recent high of -11.75 and -29.21% above the recent low of -117.72.

Score

Industry at a Glance

Previous score

7.25

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 40/205

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of iRhythm Technologies Inc is 8.63, ranking 19 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 220.00, with a high of 244.00 and a low of 194.00.

Score

Industry at a Glance

Previous score

8.63

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of iRhythm Technologies Inc is 6.58, ranking 123 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 175.84 and the support level at 131.26, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.61

Change

-0.03

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of iRhythm Technologies Inc is 10.00, ranking 1 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 107.36%, representing a quarter-over-quarter decrease of 4.14%. The largest institutional shareholder is The Vanguard, holding a total of 3.30M shares, representing 10.25% of shares outstanding, with 5.53% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

3.23M

+0.13%

BlackRock Institutional Trust Company, N.A.

2.37M

+1.62%

Sands Capital Management, LLC

Star Investors

2.24M

-23.30%

Artisan Partners Limited Partnership

2.57M

-6.32%

Capital Research Global Investors

1.18M

-21.44%

State Street Investment Management (US)

847.88K

-2.38%

Geode Capital Management, L.L.C.

790.10K

+2.97%

William Blair & Company, L.L.C. (Research)

740.72K

+0.19%

Eventide Asset Management, LLC

691.51K

-0.01%

Fuller & Thaler Asset Management Inc.

595.25K

+1.50%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of iRhythm Technologies Inc is 7.33, ranking 43 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.08. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.

iRhythm Technologies Inc

IRTC

7.64 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

LivaNova PLC

LIVN

8.61 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Cencora Inc

COR

8.47 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Becton Dickinson and Co

BDX

8.46 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

AxoGen Inc

AXGN

8.42 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Align Technology Inc

ALGN

8.42 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment